$SOUN
SOUNDHOUND AI, INC. Stock $soun

$soun Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000184085624000019 Filed on May 10, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q1
Revenue	$11.59M	$17.15M	$6.707M
YoY Change	72.86%	80.48%
Cost Of Revenue	$4.669M	$3.911M	$1.976M
YoY Change	136.29%	41.96%	11.45%
Gross Profit	$6.925M	$13.24M	$4.731M
YoY Change	46.37%	96.21%	87.96%
Gross Profit Margin	59.73%	77.19%	70.54%
Selling, General & Admin	$15.81M	$12.11M	$12.00M
YoY Change	31.74%	-13.31%	82.26%
% of Gross Profit	228.29%	91.49%	253.65%
Research & Development	$14.88M	$12.71M	$14.18M
YoY Change	4.89%	-40.95%	-14.81%
% of Gross Profit	214.84%	96.05%	299.81%
Depreciation & Amortization	$1.470M	$372.0K	$708.0K
YoY Change	107.63%	-55.71%	-45.2%
% of Gross Profit	21.23%	2.81%	14.97%
Operating Expenses	$30.69M	$24.82M	$26.18M
YoY Change	17.2%	-30.07%	5243.13%
Operating Profit	-$28.53M	-$11.59M	-$25.04M
YoY Change	13.94%	-59.7%	-1335.25%
Interest Expense	$5.664M	-$5.069M	$1.096M
YoY Change	416.79%	400.39%	947.7%
% of Operating Profit
Other Income/Expense, Net	-$4.185M	$666.0K	$63.00K
YoY Change	-6742.86%	80.49%	-113.49%
Pretax Income	-$32.71M	-$16.40M	-$26.04M
YoY Change	25.63%	-44.22%	6655.74%
Income Tax	$295.0K	$1.607M	$329.0K
% Of Pretax Income
Net Earnings	-$33.01M	-$18.57M	-$26.37M
YoY Change	25.18%	-39.47%	6741.09%
Net Earnings / Revenue	-284.71%	-108.3%	-393.16%
Basic Earnings Per Share	-$0.12		-$0.13
Diluted Earnings Per Share	-$0.12	-$0.07	-$0.13
COMMON SHARES
Basic Shares Outstanding	286.6M shares		205.1M shares
Diluted Shares Outstanding	286.6M shares		205.1M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$211.7M	$95.26M	$46.33M
YoY Change	357.02%	930.39%	255448.81%
Cash & Equivalents	$211.7M	$95.30M	$46.30M
Short-Term Investments
Other Short-Term Assets	$3.340M	$1.528M	$1.069M
YoY Change	212.44%	77.88%	1260.57%
Inventory
Prepaid Expenses		$924.0K	$1.651M
Receivables	$18.95M	$15.83M	$4.206M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$234.0M	$113.5M	$53.26M
YoY Change	339.45%	541.37%	54974.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.894M	$6.725M	$10.15M
YoY Change	-41.91%	-41.86%	-35.37%
Goodwill	$5.760M	$0.00
YoY Change
Intangibles	$11.58M	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$686.0K	$577.0K	$2.074M
YoY Change	-66.92%	-65.16%	-71.31%
Total Long-Term Assets	$53.39M	$37.58M	$19.55M
YoY Change	173.16%	82.89%	-85.31%
TOTAL ASSETS
Total Short-Term Assets	$234.0M	$113.5M	$53.26M
Total Long-Term Assets	$53.39M	$37.58M	$19.55M
Total Assets	$287.4M	$151.1M	$72.80M
YoY Change	294.8%	295.08%	-45.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.997M	$1.653M	$2.542M
YoY Change	17.9%	-40.92%	-63.36%
Accrued Expenses	$15.34M	$13.88M	$12.31M
YoY Change	24.66%	86.06%	2346.18%
Deferred Revenue	$3.631M	$4.310M	$5.319M
YoY Change	-31.74%	-25.84%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$16.98M
YoY Change	-100.0%	-100.0%	-72.55%
Total Short-Term Liabilities	$26.48M	$24.22M	$41.51M
YoY Change	-36.2%	-35.4%	6210.35%
LONG-TERM LIABILITIES
Long-Term Debt	$85.54M	$84.31M	$14.14M
YoY Change	505.1%	357.55%
Other Long-Term Liabilities	$4.638M	$6.420M	$4.294M
YoY Change	8.01%	49.48%	2674.44%
Total Long-Term Liabilities	$90.18M	$90.73M	$4.294M
YoY Change	2000.16%	2012.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.48M	$24.22M	$41.51M
Total Long-Term Liabilities	$90.18M	$90.73M	$4.294M
Total Liabilities	$132.0M	$123.0M	$70.42M
YoY Change	87.37%	67.34%	10604.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$625.4M	-$592.4M	-$528.5M
YoY Change	18.33%	17.98%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$155.5M	$28.17M	$2.382M
YoY Change
Total Liabilities & Shareholders Equity	$287.4M	$151.1M	$72.80M
YoY Change	294.8%	295.08%	-45.31%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q1
OPERATING ACTIVITIES
Net Income	-$33.01M	-$18.57M	-$26.37M
YoY Change	25.18%	-39.47%	6741.09%
Depreciation, Depletion And Amortization	$1.470M	$372.0K	$708.0K
YoY Change	107.63%	-55.71%	-45.2%
Cash From Operating Activities	-$21.95M	-$13.87M	-$14.47M
YoY Change	51.71%	-32.06%	6561.6%
INVESTING ACTIVITIES
Capital Expenditures	$99.00K	$58.00K	$15.00K
YoY Change	560.0%	-58.87%	-102.45%
Acquisitions	$3.689M		$0.00
YoY Change
Other Investing Activities	-$3.689M
YoY Change
Cash From Investing Activities	-$3.788M	-$58.00K	-$15.00K
YoY Change	25153.33%	-58.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$8.887M		$28.36M
YoY Change	-68.66%
Debt Paid & Issued, Net	$0.00		$4.120M
YoY Change	-100.0%
Cash From Financing Activities	$142.7M	13.06M	$51.57M
YoY Change	176.72%	-461.63%
NET CHANGE
Cash From Operating Activities	-$21.95M	-13.87M	-$14.47M
Cash From Investing Activities	-$3.788M	-58.00K	-$15.00K
Cash From Financing Activities	$142.7M	13.06M	$51.57M
Net Change In Cash	$117.1M	-866.0K	$37.09M
YoY Change	215.66%	-96.42%
FREE CASH FLOW
Cash From Operating Activities	-$21.95M	-$13.87M	-$14.47M
Capital Expenditures	$99.00K	$58.00K	$15.00K
Free Cash Flow	-$22.05M	-$13.93M	-$14.48M
YoY Change	52.24%	-32.24%	-3777.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6707000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6707000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6707000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-50737000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5542000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14878000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14184000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7290000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	3585000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	31910000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	26483000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24223000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2065000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3089000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	4087000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	4910000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	85543000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	84312000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	6819000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2024Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	2315000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	2453000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4638000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3967000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	131950000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	122954000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	70241	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	70241	shares
CY2024Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	2481000	usd
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	16227000	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	2097000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	14187000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	778503000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	606135000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-625388000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-592379000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	235000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	199000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	155479000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	28168000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	287429000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	151122000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11594000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6707000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	4669000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1976000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4875000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10267000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4162000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	605000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	40123000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-28529000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-25203000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	5664000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1096000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1479000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-802000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4185000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1898000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32714000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27101000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	295000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	329000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-33009000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-27430000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	343000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	682000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33352000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28112000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	36000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-32973000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27430000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	286596559	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	286596559	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	205082328	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	205082328	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	28168000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9171000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6979000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-33009000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	36000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	155479000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-36565000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2425000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24942000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8249000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-27430000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1950000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-33009000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-27430000	usd
CY2024Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1470000	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	708000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6979000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8249000	usd
CY2024Q1	soun	Gain Loss On Equity Line Of Credit Financing Program GainLossOnEquityLineOfCreditFinancingProgram	0	usd
CY2023Q1	soun	Gain Loss On Equity Line Of Credit Financing Program GainLossOnEquityLineOfCreditFinancingProgram	-571000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1231000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	16000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	743000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	894000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	55000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	0	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4162000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-281000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-45000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1248000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-754000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	533000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-653000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-939000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-126000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-93000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-186000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	905000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-256000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-673000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4556000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-888000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-963000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1606000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2603000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-222000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21948000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14540000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	99000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3689000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3788000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	24942000	usd
CY2024Q1	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	0	usd
CY2023Q1	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	28683000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	137274000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8887000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2425000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	250000	usd
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3435000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4120000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	28000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	39000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	142698000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51641000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	103000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	117065000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37086000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109035000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9475000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	226100000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46561000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	211744000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46331000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	14356000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	230000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	226100000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46561000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	3539000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1074000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	727000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	550000	usd
CY2024Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	12090000	usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	915000	usd
CY2024Q1	soun	Unpaid Issuance Costs In Connection With The Eloc Program UnpaidIssuanceCostsInConnectionWithTheELOCProgram	0	usd
CY2023Q1	soun	Unpaid Issuance Costs In Connection With The Eloc Program UnpaidIssuanceCostsInConnectionWithTheELOCProgram	437000	usd
CY2024Q1	soun	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	0	usd
CY2023Q1	soun	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	323000	usd
CY2024Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	83000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	usd
CY2024Q1	soun	Fair Value Of Class A Common Stock Issued For Business Combination FairValueOfClassACommonStockIssuedForBusinessCombination	10295000	usd
CY2023Q1	soun	Fair Value Of Class A Common Stock Issued For Business Combination FairValueOfClassACommonStockIssuedForBusinessCombination	0	usd
CY2024Q1	soun	Fair Value Of Deferred Consideration FairValueOfDeferredConsideration	143000	usd
CY2023Q1	soun	Fair Value Of Deferred Consideration FairValueOfDeferredConsideration	0	usd
CY2024Q1	soun	Fair Value Of Issuable Acquisition Contingent Consideration FairValueOfIssuableAcquisitionContingentConsideration	1676000	usd
CY2023Q1	soun	Fair Value Of Issuable Acquisition Contingent Consideration FairValueOfIssuableAcquisitionContingentConsideration	0	usd
CY2024Q1	soun	Fair Value Of Acquisition Related Holdback Liability FairValueOfAcquisitionRelatedHoldbackLiability	981000	usd
CY2023Q1	soun	Fair Value Of Acquisition Related Holdback Liability FairValueOfAcquisitionRelatedHoldbackLiability	0	usd
CY2024Q1	soun	Deferred Financing Costs Included In Accrued Liabilities DeferredFinancingCostsIncludedInAccruedLiabilities	200000	usd
CY2023Q1	soun	Deferred Financing Costs Included In Accrued Liabilities DeferredFinancingCostsIncludedInAccruedLiabilities	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-33000000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-625400000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	211700000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Reclassification</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain accounts in the prior year condensed consolidated financial statements were reclassified to conform with the current year presentation. The reclassification had an immaterial impact on our consolidated balance sheet in the prior year period.</span></div>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosures in the consolidated financial statements and accompanying notes. Such estimates include revenue recognition, allowance for credit losses, accrued liabilities, derivative and warrant liabilities, calculation of the incremental borrowing rate, financial instruments recorded at fair value on a recurring basis, the accounting for business combinations and allocating purchase price, valuation and estimating the useful life of identifiable intangible assets, probability of achievement of revenue estimates related to contingent earnout consideration and performance-based equity awards, valuation of deferred tax assets and uncertain tax positions and the fair value of common stock and other assumptions used to measure stock-based compensation expense. The Company bases its estimates on historical experience, the current economic environment, and on assumptions it believes are reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from changes in the economic environment will be reflected in the financial statements in future periods. Actual results could differ materially from those estimates.</span></div>
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Concentrations of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents, the balances of which frequently exceed federally insured limits. The Company regularly monitors its credit risk exposure and takes steps to mitigate the likelihood of these exposures resulting in actual loss.</span></div>
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q1	us-gaap	Revenue Performance Obligation Description Of Timing RevenuePerformanceObligationDescriptionOfTiming	Hosted services, along with non-distinct customization, integration, maintenance and support professional services, allow customers to access the Houndify platform over the contract period without taking possession of the software.
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11594000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6707000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11594000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11594000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11594000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	3400000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	8700000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13400000	usd
CY2024Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	7068000	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5138000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5036000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	6642000	usd
CY2024Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	1251000	usd
CY2023Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	0	usd
CY2024Q1	us-gaap	Contract With Customer Receivable Allowance For Credit Loss Noncurrent ContractWithCustomerReceivableAllowanceForCreditLossNoncurrent	13855000	usd
CY2023Q4	us-gaap	Contract With Customer Receivable Allowance For Credit Loss Noncurrent ContractWithCustomerReceivableAllowanceForCreditLossNoncurrent	16492000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1900000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1800000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	11800000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	6300000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3400000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P2Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P5Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2100000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P5Y
CY2023Q4	us-gaap	Goodwill Goodwill	0	usd
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5760000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	5760000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	12705000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1125000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11580000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1100000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	500000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3030000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4156000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3194000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1200000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11580000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8141000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6961000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	3158000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3792000	usd
CY2024Q1	soun	Accrued Lender Fees AccruedLenderFees	3501000	usd
CY2023Q4	soun	Accrued Lender Fees AccruedLenderFees	2603000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	541000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	528000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15341000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13884000	usd
CY2021Q3	us-gaap	Longterm Purchase Commitment Period LongtermPurchaseCommitmentPeriod	P7Y
CY2024Q1	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	8250000	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	14000000	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	16000000	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	24000000	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	24000000	usd
CY2024Q1	us-gaap	Contractual Obligation ContractualObligation	86250000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	400000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	100000000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	100000000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	14457000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	85543000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	14457000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	15688000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	85543000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	84312000	usd
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.40
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	180	employee
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	3600000	usd
CY2023Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	1300000	usd
CY2024Q1	soun	Gain Loss On Stock Conversion GainLossOnStockConversion	0	usd
CY2024Q1	soun	Gain Loss On Stock Conversion GainLossOnStockConversion	0	usd
CY2022Q2	soun	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3700000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6979000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8249000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	1815000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	157000	usd
CY2024Q1	soun	Gain Loss On Equity Line Of Credit Financing Program GainLossOnEquityLineOfCreditFinancingProgram	0	usd
CY2023Q1	soun	Gain Loss On Equity Line Of Credit Financing Program GainLossOnEquityLineOfCreditFinancingProgram	-571000	usd
CY2024Q1	soun	Equity Line Of Credit Commitment Fees And Reimbursement Costs EquityLineOfCreditCommitmentFeesAndReimbursementCosts	0	usd
CY2023Q1	soun	Equity Line Of Credit Commitment Fees And Reimbursement Costs EquityLineOfCreditCommitmentFeesAndReimbursementCosts	325000	usd
CY2024Q1	soun	Other Income Expense Net OtherIncomeExpenseNet	-336000	usd
CY2023Q1	soun	Other Income Expense Net OtherIncomeExpenseNet	-63000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1479000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-802000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-33009000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-27430000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	343000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	682000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33352000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28112000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	286596559	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	286596559	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	205082328	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	205082328	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	40700734	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	63452307	shares
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32714000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27101000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	295000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	329000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0090
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0121
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13509000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	24131000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	82300000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4003000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	118968000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	567794000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-554179000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38610000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	157578000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6424000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-16483000	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-835000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6407000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22890000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-23307000	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	877000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24184000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13713000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-41685000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1638000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8306000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-49991000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1559000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-52296000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	567794000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-554179000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-23307000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-50737000	usd
	soun	Gain Loss On Equity Line Of Credit Financing Program GainLossOnEquityLineOfCreditFinancingProgram	-1901000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-363000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5295000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34201000	usd
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	71455000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	154558000	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
	soun	Non Cash Debt Discount NonCashDebtDiscount	4136000	usd
	us-gaap	Stock Issued1 StockIssued1	915000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1642000	usd
CY2023Q1	us-gaap	Assets Assets	72371000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	507858000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-530872000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1950000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	72371000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7290000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-25203000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-802000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1898000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27101000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-27430000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	682000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28112000	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	507858000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-530872000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-27430000	usd
CY2023Q1	soun	Gain Loss On Equity Line Of Credit Financing Program GainLossOnEquityLineOfCreditFinancingProgram	-571000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-186000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4556000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14540000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	250000	usd
CY2023Q1	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	28683000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51641000	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	915000	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001840856-24-000019-index-headers.html	Edgar Link	pending
0001840856-24-000019-index.html	Edgar Link	pending
0001840856-24-000019.txt	Edgar Link	pending
0001840856-24-000019-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
soun-20240331.htm	Edgar Link	pending
soun-20240331.xsd	Edgar Link	pending
soun-20240331x10qxexx311.htm	Edgar Link	pending
soun-20240331x10qxexx312.htm	Edgar Link	pending
soun-20240331x10qxexx321.htm	Edgar Link	pending
soun-20240331x10qxexx322.htm	Edgar Link	pending
soun-20240331_def.xml	Edgar Link	unprocessable
soun-20240331_lab.xml	Edgar Link	unprocessable
soun-20240331_pre.xml	Edgar Link	unprocessable
soun-20240331_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
soun-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SOUN
SOUNDHOUND AI, INC. Stock $soun

2024 Q1 Form 10-Q Financial Statement

#000184085624000019 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOUN SOUNDHOUND AI, INC. Stock $soun

2024 Q1 Form 10-Q Financial Statement

#000184085624000019 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOUN
SOUNDHOUND AI, INC. Stock $soun